In clinical trials of a self-administered drug, repeated measures of a labo
ratory marker, which is affected by study medication and collected in all t
reatment arms, can provide valuable information on population and individua
l summaries of compliance. In this paper. we introduce a general finite mix
ture of nonlinear hierarchical models that allows estimates of component me
mbership probabilities and random effect distributions for longitudinal dat
a arising from multiple subpopulations, such as from noncomplying and compl
ying subgroups in clinical trials. We outline a sampling strategy for fitti
ng these models, which consists of a sequence of Gibbs. Metropolis-Hastings
, and reversible jump steps, where the latter is required for switching bet
ween component models of different dimensions. Our model is applied to iden
tify noncomplying subjects in the placebo arm of a clinical trial assessing
the effectiveness of zidovudine (AZT) in the treatment of patients with HI
V, where noncompliance was defined as initiation of AZT during the trial wi
thout the investigators' knowledge. We fit a hierarchical nonlinear change
point model for increases in the marker MCV (mean corpuscular volume of ery
throcytes) for subjects who noncomply and a constant mean random effects mo
del for those who comply. As part of our Fully Bayesian analysis, we assess
the sensitivity of conclusions to prior and modeling assumptions and demon
strate how external information and covariates call be incorporated to dist
inguish subgroups.